Acute bacterial sialadenitis and suppurative parotitis
Antibiotics are used when salivary gland infection is bacterial (acute suppurative sialadenitis or suppurative parotitis). Empiric regimens are selected to cover common oral flora, especially Staphylococcus aureus and anaerobes, and are then modified based on culture when available [1], [2].
Empiric oral antibiotics
Common empiric oral antibiotic options include:
- Amoxicillin/clavulanate (covers oral anaerobes plus S. aureus) [1], [2].
- Clindamycin (active against S. aureus and anaerobic oral organisms) [1], [2].
- Dicloxacillin (coverage for S. aureus; used as an alternative in some reference antibiotic selections) [1].
Empiric parenteral antibiotics
Common empiric inpatient or severe infection antibiotic options include:
- Ampicillin/sulbactam (broad coverage for oral aerobic and anaerobic pathogens) [1].
- Nafcillin (anti-staphylococcal option in some antibiotic selections) [1].
- Flucloxacillin (anti-S. aureus option in some institutional empiric protocols) [3].
Antibiotic selection based on suspected pathogens
Selection is typically guided by likely organisms:
- Staphylococcus aureus is frequently implicated in bacterial sialadenitis/suppurative parotitis [1], [3].
- Anaerobic oral organisms are also commonly implicated [2], [4].
- MRSA risk or confirmed MRSA infection supports MRSA-active therapy (example options listed in sialadenitis antibiotic references include linezolid or vancomycin, sometimes with additional anaerobic coverage when polymicrobial infection is suspected) [1].
Culture and abscess-directed management
Aspiration or drainage is recommended when pus is present or an abscess is suspected, with samples sent for microscopy and culture to guide antibiotic modification [3].
Common antibiotic-coverage gaps to avoid
Coverage should generally include anaerobes when bacterial suppurative disease is present, because anaerobic oral organisms are common contributors [2], [4].
Clinical safety notes
Antibiotic choice should account for penicillin allergy history and local resistance patterns, and therapy should be adjusted to culture and sensitivity when obtained [1], [3].